These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22204330)

  • 1. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
    Nagy B; Miszti-Blasius K; Kerenyi A; Clemetson KJ; Kappelmayer J
    Curr Med Chem; 2012; 19(4):518-31. PubMed ID: 22204330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived chemokines in atherosclerosis.
    Duchene J; von Hundelshausen P
    Hamostaseologie; 2015; 35(2):137-41. PubMed ID: 25592448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelets in inflammation and cancer: novel therapeutic strategies.
    Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets in atherosclerosis.
    Lievens D; von Hundelshausen P
    Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet dysfunction in vascular pathologies and how can it be treated.
    Alexandru N; Popov D; Georgescu A
    Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.
    Arazi HC; Badimon JJ
    Curr Pharm Des; 2012; 18(28):4311-25. PubMed ID: 22236116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-mediated inflammation in cardiovascular disease. Potential role of platelet-endothelium interactions.
    Tsoumani ME; Kalantzi KI; Goudevenos IA; Tselepis AD
    Curr Vasc Pharmacol; 2012 Sep; 10(5):539-49. PubMed ID: 22338568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated platelets and atherosclerosis.
    Aukrust P; Halvorsen B; Ueland T; Michelsen AE; Skjelland M; Gullestad L; Yndestad A; Otterdal K
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1297-307. PubMed ID: 20828352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activity in the pathophysiology of inflammatory bowel diseases.
    Chen C; Li Y; Yu Z; Liu Z; Shi Y; Lewandowska U; Sobczak M; Fichna J; Kreis M
    Curr Drug Targets; 2015; 16(3):219-25. PubMed ID: 25585124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.
    Steinhubl SR; Badimon JJ; Bhatt DL; Herbert JM; Lüscher TF
    Vasc Med; 2007 May; 12(2):113-22. PubMed ID: 17615799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived chemokines in inflammation and atherosclerosis.
    Bakogiannis C; Sachse M; Stamatelopoulos K; Stellos K
    Cytokine; 2019 Oct; 122():154157. PubMed ID: 29198385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets.
    Schwarz UR; Kobsar AL; Koksch M; Walter U; Eigenthaler M
    Biochem Pharmacol; 2000 Nov; 60(9):1399-407. PubMed ID: 11008134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets as versatile regulators of cutaneous inflammation.
    Katoh N
    J Dermatol Sci; 2009 Feb; 53(2):89-95. PubMed ID: 18922681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated and lipid-mediated platelet function in atherosclerosis.
    Ahmadsei M; Lievens D; Weber C; von Hundelshausen P; Gerdes N
    Curr Opin Lipidol; 2015 Oct; 26(5):438-48. PubMed ID: 26270811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and their chemokines in atherosclerosis-clinical applications.
    von Hundelshausen P; Schmitt MM
    Front Physiol; 2014; 5():294. PubMed ID: 25152735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet biology and functions: new concepts and clinical perspectives.
    van der Meijden PEJ; Heemskerk JWM
    Nat Rev Cardiol; 2019 Mar; 16(3):166-179. PubMed ID: 30429532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet turnover in atherothrombotic disease.
    Lordkipanidzé M
    Curr Pharm Des; 2012; 18(33):5328-43. PubMed ID: 22724418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.